About OrbiMed

OrbiMed is a global investment firm that invests in companies engaged in the discovery and development of biopharmaceutical products, medical technologies, medical devices, diagnostics, drug discovery tools, and healthcare information technology and services companies.

Doctor touching screen in operating room

Healthcare Focus

The global healthcare industry sits at the intersection of several powerful long-term growth trends led by global demographics and the ineluctable advance of scientific innovation in treating disease.

These trends have caused a steady increase in the level of healthcare spending in the industrialized world, led by the U.S. which now spends over 17% of its GDP on healthcare. We believe the healthcare industry’s powerful growth profile coupled with its magnitude and complexity create myriad investment opportunities.

Our Strategies

OrbiMed invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies. Investments are made in one of three strategies: public equity, private equity, and private credit/royalty.

Private Equity Icon

Private Equity IconPrivate Equity

OrbiMed's private equity strategy is broad and flexible, investing from start-ups through growth equity. OrbiMed is typically a lead investor, helping to build our portfolio companies into market leaders. We invest globally, including across North America, Asia, and Europe.

Private Credit / Royalty Icon

Private Credit / Royalty Icon Private Credit/Royalty

OrbiMed provides commercial-stage healthcare companies with non-dilutive structured debt capital. Additionally, OrbiMed can monetize royalty streams, providing valuable financing solutions to owners of intellectual property.

Public Equity Icon

Public Equity IconPublic Equity

OrbiMed manages a series of public equity funds, including long/short event-driven funds and closed-end investment trusts. We invest across all types of publicly-traded companies, from biopharmaceuticals to medical devices and healthcare services worldwide.

Firm History

To thrive, organisms need to adapt and grow. So do investment firms. Through 25 years of volatile, changing investment environments, we've embraced new opportunities and expanded our global footprint.


OrbiMed's investment business was founded in New York City


Launched our first long/ short fund and made
our first venture capital investment


Launched our first dedicated venture capital fund


Opened offices in San Francisco and Shanghai, China


Opened office in Herzliya, Israel


Launched our first dedicated royalty/credit fund


Hired our 100th employee


Opened office in Hong Kong


Opened office in London

Investing with Impact

We seek companies focused on responsible, sustainable growth to build long-term shareholder value, as outlined in our Responsible Investing Policy.

Delivering New Cures Icon

Delivering New Cures IconDelivering New Cures

Over 60 new healthcare therapies have been successfully developed and brought to patients by OrbiMed’s venture capital portfolio companies.

Solving the Greatest Needs Icon

Solving the Greatest Needs IconSolving the Greatest Needs

OrbiMed has committed over $2 billion to invest in developing-country healthcare, from maternal care hospitals in India to dialysis centers in China.

Starting New Companies Icon

Starting New Companies IconStarting New Companies

OrbiMed has backed over 90 life sciences start-ups, pushing the boundaries of medicine to achieve breakthroughs for patients.

Making a Difference Icon

Making a Difference IconMaking a Difference

Through a charitable matching program and paid time off for community service, we empower team members to become positive changemakers in their communities.

img img img img img img img img img